DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Methotrexate - 1 cisplatin - 1 China's - 1 Senators Gary Peters - 1 Debbie Stabenow - 1 Fresenius Kabi - 1 Dawn Deslippe - 1 Diane Marley - 1
Top related locs:
United States U.S India WINDSOR Ontario carboplatin
Top related orgs:
Drug Administration - 2 FDA - 2 National Cancer Institute - 2 U.S - 2 . Food - 1 Pharmaceutical - 1 Senators - 1 Intas Pharmaceuticals - 1

Search resuls for: "Intas Pharmaceuticals"


2 mentions found


☆ U.S. seeks new suppliers of highly used cancer drug methotrexate in short supply
  + stars: | 2023-06-09 | by ( ) www.cnbc.com   time to read: +2 min
The U.S. Food and Drug Administration said on Friday it is seeking new suppliers to ease shortages of methotrexate, one of the most commonly used cancer drugs, building on its push to shore up two other scarce chemotherapy medicines. An FDA spokesperson told Reuters the agency is looking for temporary importation options for the drug, which has been in shortage since March. Methotrexate is an injected drug used to treat a wide variety of cancers ranging from acute lymphoblastic leukemia in children, breast cancer, lung cancer, bone cancers and certain types of head and neck cancers, according to the National Cancer Institute. Last week, the FDA said it was looking for additional temporary suppliers for two other cancer chemotherapies, cisplatin and carboplatin. According to the American Society of Health-System Pharmacists, suppliers with methotrexate injections in shortage or on back order include Accord Healthcare, Fresenius Kabi, Pfizer , Teva and Hikma Pharmaceuticals .
Persons: Methotrexate, cisplatin, China's, Senators Gary Peters, Debbie Stabenow, Fresenius Kabi Organizations: . Food, Drug Administration, FDA, Reuters, National Cancer Institute, Pharmaceutical, U.S, Senators, Intas Pharmaceuticals, Healthcare, American Society of Health, System Pharmacists, Accord Healthcare, Pfizer, Teva, Hikma Pharmaceuticals Locations: United States, India, U.S
☆ FDA considers temporary cancer drug imports from unapproved companies to ease U.S. shortage
  + stars: | 2023-06-01 | by ( Spencer Kimball | ) www.cnbc.com   time to read: +5 min
She is one of hundreds of Ontario cancer patients who received diluted chemotherapy in the last year and who are still undergoing treatment to beat the disease. The FDA in the past has taken similar action to loosen restrictions on imports when faced with drug shortages. At least 14 cancer drugs are currently in short supply across the U.S. Up to 20% of cancer patients rely on platinum-based chemotherapy drugs such as cisplatin and carboplatin for treatment, according to the National Cancer Institute. Some cancer patients could die if the shortages are not quickly resolved, doctors said.
Persons: Dawn Deslippe, Diane Marley, Richard Lautens, Drug Administration –, Julie Gralow, We're, Gralow, —, Abdul Rafeh Naqash, Naqash, Philip Schwieterman, Schwieterman Organizations: Windsor Regional Hospital, Toronto Star, Getty, Drug Administration, CNBC, FDA, U.S, The American Society of Clinical Oncology, World Health, Pharmaceuticals, National Cancer Institute, American Society of Clinical Oncology, Stephenson Cancer Center, University of Oklahoma, University of Kentucky, kiwis Locations: WINDSOR, Ontario, United States, U.S, carboplatin
0 next >>
Total: 2